Background: The aim of this systematic review is to assess the impact of primary treatments with curative intention in patients with localized prostate cancer, measured with Patient-Reported Outcomes (PROs), and to examine differences among modalities within treatments. Methods: We conducted a systematic literature search for January 2005-March 2017 following PRISMA guidelines, including longitudinal studies measuring disease-specific PROs in localized prostate cancer patients with a follow-up from pre- to post-treatment (≥1 year). Two reviewers independently extracted data and assessed risk of bias. The study is registered in PROSPERO: CRD42015019747. Results: Of 148 identified studies, 60 were included in the meta-analyses. At the...
ImportanceUnderstanding the adverse effects of contemporary approaches to localized prostate cancer ...
Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and ...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Background: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Background: Robust data on patient-reported outcome measures comparing treatments for clinically loc...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Background: The aim of this study was to compare oncologic outcomes of radical prostatectomy (RP) wi...
Background: The aim of this study was to compare oncologic outcomes of radical prostatectomy (RP) wi...
BACKGROUND Robust data on patient-reported outcome measures comparing treatments for clinically loca...
ImportanceUnderstanding the adverse effects of contemporary approaches to localized prostate cancer ...
Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and ...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Background: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
BACKGROUND: The aim of this systematic review is to assess the impact of primary treatments with cur...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Background: Robust data on patient-reported outcome measures comparing treatments for clinically loc...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Context: Current evidence-based management for clinically localised prostate cancer includes active ...
Background: The aim of this study was to compare oncologic outcomes of radical prostatectomy (RP) wi...
Background: The aim of this study was to compare oncologic outcomes of radical prostatectomy (RP) wi...
BACKGROUND Robust data on patient-reported outcome measures comparing treatments for clinically loca...
ImportanceUnderstanding the adverse effects of contemporary approaches to localized prostate cancer ...
Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and ...
Background Robust data on patient-reported outcome measures comparing treatments for clinically loca...